zepbound tirzepatide injection Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity It’s also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound™ (tirzepatide) Approved for Chronic
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


























